Haley M Zylberberg1, Ryan T Demmer, Joseph A Murray, Peter H R Green, Benjamin Lebwohl. 1. aDepartment of Medicine, Division of Digestive and Liver Diseases, Columbia University College of Physicians and Surgeons bDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York cDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
BACKGROUND: There is uncertainty regarding the prevalence of psychiatric illnesses in patients with celiac disease (CD) and people who avoid gluten (PWAG) without a diagnosis of CD. PARTICIPANTS AND METHODS: We obtained data from 22 274 participants from the 2009-2014 National Health and Nutrition Examination Survey to compare the prevalence of depression, insomnia, quality-of-life variables, and psychotropic medication use in CD participants and PWAGs to controls. We used multivariable logistic regression to assess for independent associations between CD/PWAG status and the outcomes of these variables. RESULTS: Depression was present in 8.2% of controls compared with 3.9% of participants with CD (P=0.18) and 2.9% of PWAGs (P=0.002). After adjustment for age, sex, race, income, and access to healthcare, PWAGs maintained lower odds of depression compared with controls (odds ratio=0.25; 95% confidence interval: 0.12-0.51; P=0.0001). The prevalence estimates of sleep difficulty among controls (27.3%) compared to participants with CD or PWAGs were 37.7% (P=0.15) and 34.1% (P=0.11). Those with diagnosed CD had increased odds of sleep difficulty (odds ratio=2.41; 95% confidence interval 1.04-5.60), but this was no longer significant after multivariable adjustment (P=0.17). CONCLUSION: Among a nationally representative US sample, participants with CD overall showed no increased odds of depression or sleep difficulty. PWAGs showed lower odds of depression compared with controls. Future research should investigate the relationship between a diagnosis of CD and the development of psychiatric conditions.
BACKGROUND: There is uncertainty regarding the prevalence of psychiatric illnesses in patients with celiac disease (CD) and people who avoid gluten (PWAG) without a diagnosis of CD. PARTICIPANTS AND METHODS: We obtained data from 22 274 participants from the 2009-2014 National Health and Nutrition Examination Survey to compare the prevalence of depression, insomnia, quality-of-life variables, and psychotropic medication use in CD participants and PWAGs to controls. We used multivariable logistic regression to assess for independent associations between CD/PWAG status and the outcomes of these variables. RESULTS:Depression was present in 8.2% of controls compared with 3.9% of participants with CD (P=0.18) and 2.9% of PWAGs (P=0.002). After adjustment for age, sex, race, income, and access to healthcare, PWAGs maintained lower odds of depression compared with controls (odds ratio=0.25; 95% confidence interval: 0.12-0.51; P=0.0001). The prevalence estimates of sleep difficulty among controls (27.3%) compared to participants with CD or PWAGs were 37.7% (P=0.15) and 34.1% (P=0.11). Those with diagnosed CD had increased odds of sleep difficulty (odds ratio=2.41; 95% confidence interval 1.04-5.60), but this was no longer significant after multivariable adjustment (P=0.17). CONCLUSION: Among a nationally representative US sample, participants with CD overall showed no increased odds of depression or sleep difficulty. PWAGs showed lower odds of depression compared with controls. Future research should investigate the relationship between a diagnosis of CD and the development of psychiatric conditions.
Authors: Winfried Häuser; Karl-Heinz Janke; Bodo Klump; Michael Gregor; Andreas Hinz Journal: World J Gastroenterol Date: 2010-06-14 Impact factor: 5.742
Authors: Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci Journal: Gut Date: 2012-02-16 Impact factor: 23.059
Authors: Jonas F Ludvigsson; Johan Reutfors; Urban Osby; Anders Ekbom; Scott M Montgomery Journal: J Affect Disord Date: 2006-10-06 Impact factor: 4.839
Authors: M Siniscalchi; P Iovino; R Tortora; S Forestiero; A Somma; L Capuano; M D Franzese; F Sabbatini; C Ciacci Journal: Aliment Pharmacol Ther Date: 2005-09-01 Impact factor: 8.171
Authors: Abhik Roy; Maria Minaya; Milka Monegro; Jude Fleming; Reuben K Wong; Suzanne Lewis; Benjamin Lebwohl; Peter H R Green Journal: Dig Dis Sci Date: 2016-04-28 Impact factor: 3.199
Authors: Iwona Kaliciak; Konstanty Drogowski; Aleksandra Garczyk; Stanisław Kopeć; Paulina Horwat; Paweł Bogdański; Marta Stelmach-Mardas; Marcin Mardas Journal: Nutrients Date: 2022-05-16 Impact factor: 6.706
Authors: Iain D Croall; Nick Trott; Anupam Rej; Imran Aziz; David J O'Brien; Harvey A George; Mohammed Y Hossain; Lauren J S Marks; Jessica I Richardson; Rebecca Rigby; Marios Hadjivassiliou; Nigel Hoggard; David S Sanders Journal: Nutrients Date: 2019-06-05 Impact factor: 5.717
Authors: Filippo Vernia; Mirko Di Ruscio; Antonio Ciccone; Angelo Viscido; Giuseppe Frieri; Gianpiero Stefanelli; Giovanni Latella Journal: Int J Med Sci Date: 2021-01-01 Impact factor: 3.738